Gufic Biosciences Limited

NSE GUFICBIO.NS

Gufic Biosciences Limited Shareholders' Equity for the year ending March 31, 2024: USD 63.85 M

Gufic Biosciences Limited Shareholders' Equity is USD 63.85 M for the year ending March 31, 2024, a 50.88% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Gufic Biosciences Limited Shareholders' Equity for the year ending March 31, 2023 was USD 42.32 M, a 19.40% change year over year.
Gufic Biosciences Limited Shareholders' Equity for the year ending March 31, 2022 was USD 35.44 M, a 49.63% change year over year.
Gufic Biosciences Limited Shareholders' Equity for the year ending March 31, 2021 was USD 23.69 M, a 86.22% change year over year.
Gufic Biosciences Limited Shareholders' Equity for the year ending March 31, 2020 was USD 12.72 M, a 17.31% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

NSE: GUFICBIO.NS

Gufic Biosciences Limited

CEO	Mr. Pranav Jayesh Choksi
IPO Date	Oct. 19, 2004
Location	India
Headquarters	SM House
Employees	1,491
Sector	Health Care
Industries Pharmaceuticals

Description

Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to more than 20 countries. The company was founded in 1970 and is based in Mumbai, India.

Key trends

Past 5 years